Meningovascular syphilis and improvement with tissue-plasminogen activator (T-PA).
Han
Ji H
JH
Lee
Christopher C
CC
Crupi
Robert S
RS
D000328:Adult; D003937:Diagnosis, Differential; D004401:Dysarthria / Q000382:microbiology; D004638:Emergency Treatment / Q000379:methods; D005158:Facial Paralysis / Q000382:microbiology; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010291:Paresis / Q000382:microbiology; D010400:Penicillin G / Q000627:therapeutic use; D010960:Plasminogen Activators / Q000494:pharmacology / Q000627:therapeutic use*; D013606:Tabes Dorsalis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D014715:Vertebrobasilar Insufficiency / Q000382:microbiology
D005343:Fibrinolytic Agents; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D010400:Penicillin G